Common drug-resistant superbug developed fast resistance to ﾑlast resortﾒ antibiotic
On Jun. 7, 2022, the University of Oxford reported new research has found that Pseudomonas bacterium develops resistance…
Pfizer announced investment $120 million to produce COVID-19 oral treatment in the U.S.
On Jun. 6, 2022, Pfizer further strengthened its commitment to United States manufacturing with a $120 million investment…
Genetically modified corn does not damage non-target organisms
On Jun. 6, 2022, the USDA reported that the largest, highest quality analysis of data ever conducted revealed…
Serological evidence for SARS-CoV-2 in lactating cows published
On Jun. 4, 2022, researchers reported that in areas with large cattle populations and a high prevalence of…
Novavax filed in the UK for expanded conditional Marketing Authorization of COVID-19 vaccination booster in adult
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
USDA confirmed highly pathogenic Avian influenza in Georgia
On Jun. 2, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
Immune modulator drugs improved survival for people hospitalized with COVID-19
On Jun. 2, 2022, the U.S. National Institutes of Health announced that a large randomized, placebo-controlled clinical trial…
Food allergy associated with lower risk of SARS-CoV-2 infection
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
Novavax initiated phase 3 trial of its COVID-19 Omicron strain vaccine as a booster
On May 31, 2022, Novavax announced the initiation of its Phase 3 strain change trial to determine if…
Ultima Genomics delivered the $100 genome
On May 31, 2022, Ultima Genomics emerged from stealth business mode with a new high-throughput, low-cost sequencing platform…
BD launched high-throughput molecular combination test for COVID-19 and influenza A/B
On May 26, 2022, BD (Becton, Dickinson) announced a new high-throughput molecular diagnostic combination test for SARS-CoV-2 and…
Relief reports that its U.S. collaboration partner announced DSMB recommended termination of ACTIV-3b study in critical COVID-19
On May 26, 2022, RELIEF THERAPEUTICS announced that the parent company, NRx Pharmaceuticals, of its collaboration partner with…
Pfizer-BioNTech COVID-19 vaccine demonstrated strong immune response in children 6 months to under 5 years of age following third dose
On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…
Roche developed unique PCR tests to detect the monkeypox virus
On May 25, 2022, Roche and its subsidiary TIB Molbiol announced they had developed three unique LightMixï¾® Modular…
Novavax participated in Oxford University Com-COV3 booster trial of COVID-19 vaccines in adolescents aged 12 through 15
On May 25, 2022, Novavax announced it was participating in a stage of the COVID-19 Vaccine Schedule Combinations…
The Advanced Research Projects Agency for Health (ARPA-H) was established
On May 25, 2022, the Health and Human Servicesagency (HHS) announced the formal establishment of the Advanced Research…
Computer model predicted dominant SARS-CoV-2 variants
On May 24, 2022, scientists at the Broad Institute of MIT and Harvard and the University of Massachusetts…
Jaguar Health announced launch of the first U.S. Canine Cancer Registry and Canine Cancer Care Index
On May 23, 2022, Jaguar Health announced the launch of Canine Cancer: Take C.H.A.R.G.E. (Canine Health And ReGistry…
WHO announced nulti-country monkeypox outbreak in non-endemic countries
On May 21, 2022, the WHO announced that since May 13, 2022, cases of monkeypox had been reported…
Novavax filed in the EU for expanded conditional Marketing Authorization of COVID-19 vaccine as booster in individuals aged 18 and over
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency to expand…
WHO validated 11th vaccine for COVID-19
On May 19, 2022, WHO issued an emergency use listing (EUL) for CONVIDECIA, a vaccine manufactured by CanSino…
NIH announced antiviral drug development awards
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
SARS-CoV-2 RNA can persist in stool months after respiratory tract clears virus
On May 18, 2022, SARS-CoV-2, or at least pieces of it, sticks around longer in some infected individuals…
USDA confirmed highly pathogenic Avian influenza in New Jersey
On May 18, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
Labcorp received EUA for first non-prescription at-home collection kit for combined COVID-19, Fflu and RSV detection
On May 18, 2022, LabCorp announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and…
CDC and health partners responded to Monkeypox case in the U.S.
On May 18, 2022, scientists at the Centers for Disease Control and Prevention (CDC) announced that they were…
Study found ﾓnatural immunityﾔ from Omicron weak and limited
On May 18, 2022, researchers at Gladstone Institutes and UC San Francisco (UCSF) reported that unvaccinated people, infection…
InteliSwabï¾® COVID-19 rapid test validated to detect Omicron BA.2, BA.2.12.1, BA.3 and BA.5 subvariants
On May 17, 2022, OraSure Technologies announced that its InteliSwabï¾® COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1,…
Pfizer and BioNTech granted U.S. EUA for booster dose of COVID-19 vaccine in children 5 through 11 years of age
On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…
TGen worked with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2
On May 16, 2022, working with state and federal wildlife agencies and private and public zoos across Arizona,…